# Effect of High-Dose NAC on Patients With DPN

> **NCT04766450** · PHASE4 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 30 (estimated)

## Conditions studied

- Diabetic Neuropathies

## Interventions

- **DRUG:** Acetyl cysteine

## Key facts

- **NCT ID:** NCT04766450
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04766450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04766450, "Effect of High-Dose NAC on Patients With DPN". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04766450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*